1. Home
  2. CORT vs SUZ Comparison

CORT vs SUZ Comparison

Compare CORT & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$111.91

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Suzano S.A.

SUZ

Suzano S.A.

N/A

Current Price

$7.86

Market Cap

10.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
SUZ
Founded
1998
1924
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.8B
IPO Year
2001
2002

Fundamental Metrics

Financial Performance
Metric
CORT
SUZ
Price
$111.91
$7.86
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$96.50
N/A
AVG Volume (30 Days)
1.3M
2.3M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
2.15%
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$761,407,000.00
N/A
Revenue This Year
$26.08
$13.28
Revenue Next Year
$26.98
$13.57
P/E Ratio
$1,267.14
$5.58
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$7.56
52 Week High
$122.21
$11.54

Technical Indicators

Market Signals
Indicator
CORT
SUZ
Relative Strength Index (RSI) 65.59 34.65
Support Level $76.41 $7.56
Resistance Level $122.21 $8.61
Average True Range (ATR) 5.21 0.18
MACD 0.55 -0.05
Stochastic Oscillator 72.40 0.64

Price Performance

Historical Comparison
CORT
SUZ

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About SUZ Suzano S.A.

Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.

Share on Social Networks: